About 2-[4-[4-[[4-[[(2R)-2-ethylpyrrolidin-1-yl]methyl]-5-[4-(trifluoromethoxy)phenyl]-2-pyridinyl]carbamoyl]phenyl]piperazin-1-yl]acetic acid
2-[4-[4-[[4-[[(2R)-2-ethylpyrrolidin-1-yl]methyl]-5-[4-(trifluoromethoxy)phenyl]-2-pyridinyl]carbamoyl]phenyl]piperazin-1-yl]acetic acid (PubChem CID 139535080) has the molecular formula C32H36F3N5O4
and a molecular weight of 611.67 g/mol. Its IUPAC name is 2-[4-[4-[[4-[[(2R)-2-ethylpyrrolidin-1-yl]methyl]-5-[4-(trifluoromethoxy)phenyl]-2-pyridinyl]carbamoyl]phenyl]piperazin-1-yl]acetic acid.
Molecular Properties
| Compound Name | 2-[4-[4-[[4-[[(2R)-2-ethylpyrrolidin-1-yl]methyl]-5-[4-(trifluoromethoxy)phenyl]-2-pyridinyl]carbamoyl]phenyl]piperazin-1-yl]acetic acid |
| PubChem CID | 139535080 |
| Molecular Formula | C32H36F3N5O4 |
| Molecular Weight | 611.67 g/mol |
| Exact Mass | 611.27 |
| IUPAC Name | 2-[4-[4-[[4-[[(2R)-2-ethylpyrrolidin-1-yl]methyl]-5-[4-(trifluoromethoxy)phenyl]-2-pyridinyl]carbamoyl]phenyl]piperazin-1-yl]acetic acid |
| SMILES | CC[C@@H]1CCCN1Cc1cc(NC(=O)c2ccc(N3CCN(CC(=O)O)CC3)cc2)ncc1-c1ccc(OC(F)(F)F)cc1 |
| InChI | InChI=1S/C32H36F3N5O4/c1-2-25-4-3-13-40(25)20-24-18-29(36-19-28(24)22-7-11-27(12-8-22)44-32(33,34)35)37-31(43)23-5-9-26(10-6-23)39-16-14-38(15-17-39)21-30(41)42/h5-12,18-19,25H,2-4,13-17,20-21H2,1H3,(H,41,42)(H,36,37,43)/t25-/m1/s1 |
| InChIKey | OZSSECQMYYFVKK-RUZDIDTESA-N |
| XLogP | 5.48 |
| TPSA | 98.24 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 44 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 611.67 |
| LogP ≤ 5 | 5.48 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Analyze 2-[4-[4-[[4-[[(2R)-2-ethylpyrrolidin-1-yl]methyl]-5-[4-(trifluoromethoxy)phenyl]-2-pyridinyl]carbamoyl]phenyl]piperazin-1-yl]acetic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[4-[4-[[4-[[(2R)-2-ethylpyrrolidin-1-yl]methyl]-5-[4-(trifluoromethoxy)phenyl]-2-pyridinyl]carbamoyl]phenyl]piperazin-1-yl]acetic acid?
The IUPAC name of 2-[4-[4-[[4-[[(2R)-2-ethylpyrrolidin-1-yl]methyl]-5-[4-(trifluoromethoxy)phenyl]-2-pyridinyl]carbamoyl]phenyl]piperazin-1-yl]acetic acid (CID 139535080) is 2-[4-[4-[[4-[[(2R)-2-ethylpyrrolidin-1-yl]methyl]-5-[4-(trifluoromethoxy)phenyl]-2-pyridinyl]carbamoyl]phenyl]piperazin-1-yl]acetic acid.
What is the SMILES notation for 2-[4-[4-[[4-[[(2R)-2-ethylpyrrolidin-1-yl]methyl]-5-[4-(trifluoromethoxy)phenyl]-2-pyridinyl]carbamoyl]phenyl]piperazin-1-yl]acetic acid?
The canonical SMILES for 2-[4-[4-[[4-[[(2R)-2-ethylpyrrolidin-1-yl]methyl]-5-[4-(trifluoromethoxy)phenyl]-2-pyridinyl]carbamoyl]phenyl]piperazin-1-yl]acetic acid is CC[C@@H]1CCCN1Cc1cc(NC(=O)c2ccc(N3CCN(CC(=O)O)CC3)cc2)ncc1-c1ccc(OC(F)(F)F)cc1.
What is the InChIKey of 2-[4-[4-[[4-[[(2R)-2-ethylpyrrolidin-1-yl]methyl]-5-[4-(trifluoromethoxy)phenyl]-2-pyridinyl]carbamoyl]phenyl]piperazin-1-yl]acetic acid?
The InChIKey is OZSSECQMYYFVKK-RUZDIDTESA-N. The full InChI is InChI=1S/C32H36F3N5O4/c1-2-25-4-3-13-40(25)20-24-18-29(36-19-28(24)22-7-11-27(12-8-22)44-32(33,34)35)37-31(43)23-5-9-26(10-6-23)39-16-14-38(15-17-39)21-30(41)42/h5-12,18-19,25H,2-4,13-17,20-21H2,1H3,(H,41,42)(H,36,37,43)/t25-/m1/s1.
What are the key properties of 2-[4-[4-[[4-[[(2R)-2-ethylpyrrolidin-1-yl]methyl]-5-[4-(trifluoromethoxy)phenyl]-2-pyridinyl]carbamoyl]phenyl]piperazin-1-yl]acetic acid?
2-[4-[4-[[4-[[(2R)-2-ethylpyrrolidin-1-yl]methyl]-5-[4-(trifluoromethoxy)phenyl]-2-pyridinyl]carbamoyl]phenyl]piperazin-1-yl]acetic acid has a molecular weight of 611.67 g/mol, XLogP of 5.48, 10 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[4-[[4-[[(2R)-2-ethylpyrrolidin-1-yl]methyl]-5-[4-(trifluoromethoxy)phenyl]-2-pyridinyl]carbamoyl]phenyl]piperazin-1-yl]acetic acid is sourced from PubChem (CID 139535080), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).